159 related articles for article (PubMed ID: 19259046)
1. Factors associated with various arterial calcifications in haemodialysis patients.
Gelev S; Spasovski G; Trajkovski Z; Damjanovski G; Amitov V; Selim G; Dzekova P; Sikole A
Prilozi; 2008 Dec; 29(2):185-199. PubMed ID: 19259046
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of hemodialysis patients with intimal versus medial vascular calcifications.
Damjanovic T; Djuric S; Schlieper G; Markovic N; Dimkovic S; Radojicic Z; Krüger T; Floege J; Dimkovic N
J Nephrol; 2009; 22(3):358-66. PubMed ID: 19557712
[TBL] [Abstract][Full Text] [Related]
3. Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical practice?
Gelev S; Spasovski G; Dzikova S; Trajkovski Z; Damjanovski G; Amitov V; Sikole A
Int Urol Nephrol; 2008; 40(3):763-70. PubMed ID: 18584302
[TBL] [Abstract][Full Text] [Related]
4. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.
London GM; Guérin AP; Marchais SJ; Métivier F; Pannier B; Adda H
Nephrol Dial Transplant; 2003 Sep; 18(9):1731-40. PubMed ID: 12937218
[TBL] [Abstract][Full Text] [Related]
5. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients.
Matias PJ; Ferreira C; Jorge C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
Nephrol Dial Transplant; 2009 Feb; 24(2):611-8. PubMed ID: 18775809
[TBL] [Abstract][Full Text] [Related]
6. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence and functional effect of arteriovenous fistula calcifications, evaluated by spiral CT in chronic haemodialysis patients].
Roca-Tey R; Páez R; Rivas A; Samon R; Ibrik O; Giménez I; Viladoms J
Nefrologia; 2009; 29(3):214-21. PubMed ID: 19554054
[TBL] [Abstract][Full Text] [Related]
8. [CA-P control in haemodialysis and K/DOQI guidelines].
Rivera F; Sánchez de la Nieta MD; Echarri R; Anaya S; Carreño A; Vozmediano MC; Alcaide MP
Nefrologia; 2006; 26(3):351-7. PubMed ID: 16892824
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein levels are associated with arterial media calcification in nondiabetic patients with end-stage renal disease on long-term hemodialysis.
Marinelli A; Orlandi L; Stivali G
Clin Nephrol; 2011 Dec; 76(6):425-34. PubMed ID: 22105444
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of some nutritional parameters in hemodialysis patients over and below 65 years of age].
Bednarek-Skublewska A; Baranowicz-Gaszczyk I; Jóźwiak L; Dzik M; Majdan M; Ksiazek A
Pol Arch Med Wewn; 2005 May; 113(5):417-23. PubMed ID: 16479823
[TBL] [Abstract][Full Text] [Related]
11. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.
Jean G; Bresson E; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2009 Mar; 24(3):948-55. PubMed ID: 18852190
[TBL] [Abstract][Full Text] [Related]
12. [Cardiac valves calcifications in dialysis patients].
Klarić D; Klarić V; Kristić I
Acta Med Croatica; 2011 Oct; 65 Suppl 3():11-3. PubMed ID: 23120808
[TBL] [Abstract][Full Text] [Related]
13. Role of osteoprotegerin in vascular disorders of the end-stage renal disease patients.
Moldovan D; Kacso IM; Rusu C; Potra A; Bondor CI; Moldovan I; Patiu IM; Vladutiu D; Caprioara MG
Biomarkers; 2015 Mar; 20(2):116-22. PubMed ID: 25585925
[TBL] [Abstract][Full Text] [Related]
14. Peripheral artery calcifications evaluated by histology correlate to those detected by CT: relationships with fetuin-A and FGF-23.
Coen G; De Paolis P; Ballanti P; Pierantozzi A; Pisanò S; Sardella D; Mantella D; Pellegrino L; Silvestrini G; Iappelli M; Di Giulio S
J Nephrol; 2011; 24(3):313-21. PubMed ID: 20954136
[TBL] [Abstract][Full Text] [Related]
15. Association of cardiac valve calcification and inflammation in patients on hemodialysis.
Torun D; Sezer S; Baltali M; Adam FU; Erdem A; Ozdemir FN; Haberal M
Ren Fail; 2005; 27(2):221-6. PubMed ID: 15807189
[TBL] [Abstract][Full Text] [Related]
16. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
[TBL] [Abstract][Full Text] [Related]
17. Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients.
Mizuiri S; Nishizawa Y; Yamashita K; Ono K; Oda M; Usui K; Shigemoto K
Nephrology (Carlton); 2014 Sep; 19(9):568-73. PubMed ID: 24947687
[TBL] [Abstract][Full Text] [Related]
18. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
Arenas MD; Alvarez-Ude F; Gil MT; Soriano A; Egea JJ; Millán I; Amoedo ML; Muray S; Carretón MA
Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
Maduell F; Gorriz JL; Pallardo LM; Pons R; Santiago C;
J Nephrol; 2005; 18(6):739-48. PubMed ID: 16358233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
